JHFunds2 Capital Appreciation Value NAV JCAVX

Medalist Rating as of | See John Hancock Investment Hub
  • NAV / 1-Day Return 10.33  /  +0.10 %
  • Total Assets 1.2 Bil
  • Adj. Expense Ratio
    0.870%
  • Expense Ratio 0.870%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Moderate Allocation
  • Investment Style Large Growth
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 2.08%
  • Turnover 88%

USD | NAV as of Sep 28, 2024 | 1-Day Return as of Sep 28, 2024, 12:45 AM GMT+0

Morningstar’s Analysis JCAVX

Will JCAVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin JHFunds2 Capital Appreciation Value NAV's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings JCAVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 29.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

4.97 58.6 Mil
Technology

United States Treasury Notes 4.5%

3.62 42.7 Mil
Government

United States Treasury Notes 4%

3.48 41.1 Mil
Government

T. Rowe Price Gov. Reserve

3.31 39.0 Mil
Cash and Equivalents

UnitedHealth Group Inc

2.94 34.6 Mil
Healthcare

NVIDIA Corp

2.81 33.1 Mil
Technology

Amazon.com Inc

2.67 31.5 Mil
Consumer Cyclical

Alphabet Inc Class A

2.47 29.2 Mil
Communication Services

Danaher Corp

2.31 27.2 Mil
Healthcare

Revvity Inc

2.31 27.2 Mil
Healthcare

Sponsor Center